ID   STK4_HUMAN              Reviewed;         487 AA.
AC   Q13043; B2RCR8; Q15802; Q4G156; Q5H982; Q6PD60; Q9BR32; Q9NTZ4;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   05-OCT-2010, entry version 113.
DE   RecName: Full=Serine/threonine-protein kinase 4;
DE            EC=2.7.11.1;
DE   AltName: Full=Mammalian STE20-like protein kinase 1;
DE            Short=MST-1;
DE   AltName: Full=STE20-like kinase MST1;
DE   AltName: Full=Serine/threonine-protein kinase Krs-2;
GN   Name=STK4; Synonyms=MST1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-312.
RX   MEDLINE=95394929; PubMed=7665586; DOI=10.1074/jbc.270.37.21695;
RA   Creasy C.L., Chernoff J.;
RT   "Cloning and characterization of a human protein kinase with homology
RT   to Ste20.";
RL   J. Biol. Chem. 270:21695-21700(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   MEDLINE=96413604; PubMed=8816758; DOI=10.1073/pnas.93.19.10099;
RA   Taylor L.K., Wang H.C., Erikson R.L.;
RT   "Newly identified stress-responsive protein kinases, Krs-1 and Krs-
RT   2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:10099-10104(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21638749; PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone, Brain, and Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-7; 16-94; 118-144; 152-181; 232-259; 270-282;
RP   292-301; 333-342; 384-402; 405-413; 421-465 AND 470-481, ACETYLATION
RP   AT MET-1, AND MASS SPECTROMETRY.
RC   TISSUE=Mammary carcinoma;
RA   Bienvenut W.V., Matallanas D., Cooper W.N., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [8]
RP   FUNCTION, HOMODIMERIZATION, AND ENZYME REGULATION.
RX   PubMed=8702870; DOI=10.1074/jbc.271.35.21049;
RA   Creasy C.L., Ambrose D.M., Chernoff J.;
RT   "The Ste20-like protein kinase, Mst1, dimerizes and contains an
RT   inhibitory domain.";
RL   J. Biol. Chem. 271:21049-21053(1996).
RN   [9]
RP   SUBCELLULAR LOCATION, FUNCTION, CLEAVAGE BY CASPASE, AND MUTAGENESIS
RP   OF ASP-326 AND ASP-349.
RX   MEDLINE=21276425; PubMed=11278283; DOI=10.1074/jbc.M005109200;
RA   Lee K.-K., Ohyama T., Yajima N., Tsubuki S., Yonehara S.;
RT   "MST, a physiological caspase substrate, highly sensitizes apoptosis
RT   both upstream and downstream of caspase activation.";
RL   J. Biol. Chem. 276:19276-19285(2001).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11517310; DOI=10.1073/pnas.181161698;
RA   Ura S., Masuyama N., Graves J.D., Gotoh Y.;
RT   "Caspase cleavage of MST1 promotes nuclear translocation and chromatin
RT   condensation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:10148-10153(2001).
RN   [11]
RP   FUNCTION IN PHOSPHORYLATION OF HISTONE H2B.
RX   PubMed=12757711; DOI=10.1016/S0092-8674(03)00355-6;
RA   Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,
RA   Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
RT   "Apoptotic phosphorylation of histone H2B is mediated by mammalian
RT   sterile twenty kinase.";
RL   Cell 113:507-517(2003).
RN   [12]
RP   FUNCTION, ENZYME REGULATION, HOMODIMERIZATION, PHOSPHORYLATION AT
RP   THR-183, MUTAGENESIS OF LYS-59; THR-175; THR-177; THR-183 AND LEU-444,
RP   AND INTERACTION WITH RASSF1 AND NORE1.
RX   PubMed=15109305; DOI=10.1042/BJ20040025;
RA   Praskova M., Khoklatchev A., Ortiz-Vega S., Avruch J.;
RT   "Regulation of the MST1 kinase by autophosphorylation, by the growth
RT   inhibitory proteins, RASSF1 and NORE1, and by Ras.";
RL   Biochem. J. 381:453-462(2004).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH RASSF1.
RX   PubMed=16510573; DOI=10.1158/0008-5472.CAN-05-2951;
RA   Oh H.J., Lee K.-K., Song S.J., Jin M.S., Song M.S., Lee J.H., Im C.R.,
RA   Lee J.-O., Yonehara S., Lim D.-S.;
RT   "Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis.";
RL   Cancer Res. 66:2562-2569(2006).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH FOXO3.
RX   PubMed=16751106; DOI=10.1016/j.cell.2006.03.046;
RA   Lehtinen M.K., Yuan Z., Boag P.R., Yang Y., Villen J., Becker E.B.E.,
RA   DiBacco S., de la Iglesia N., Gygi S.P., Blackwell T.K., Bonni A.;
RT   "A conserved MST-FOXO signaling pathway mediates oxidative-stress
RT   responses and extends life span.";
RL   Cell 125:987-1001(2006).
RN   [15]
RP   INTERACTION WITH SAV1, FUNCTION, AND MUTAGENESIS OF LYS-59.
RX   PubMed=16930133; DOI=10.1111/j.1742-4658.2006.05427.x;
RA   Callus B.A., Verhagen A.M., Vaux D.L.;
RT   "Association of mammalian sterile twenty kinases, Mst1 and Mst2, with
RT   hSalvador via C-terminal coiled-coil domains, leads to its
RT   stabilization and phosphorylation.";
RL   FEBS J. 273:4264-4276(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-433, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-265; SER-320; THR-340;
RP   SER-410 AND SER-438, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3; SER-40; TYR-41;
RP   THR-175; THR-177; SER-320; SER-327; THR-329; THR-340; THR-353;
RP   THR-360; THR-367; THR-380; THR-387; SER-394; SER-410; SER-414; SER-422
RP   AND SER-438, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-162; GLN-310; MET-312; THR-355 AND
RP   LEU-416.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Stress-activated, pro-apoptotic kinase which, following
CC       caspase-cleavage, enters the nucleus and induces chromatin
CC       condensation followed by internucleosomal DNA fragmentation. Key
CC       component of the Hippo signaling pathway which plays a pivotal
CC       role in organ size control and tumor suppression by restricting
CC       proliferation and promoting apoptosis. The core of this pathway is
CC       composed of a kinase cascade wherein MST1/MST2, in complex with
CC       its regulatory protein SAV1, phosphorylates and activates LATS1/2
CC       in complex with its regulatory protein MOB1, which in turn
CC       phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ.
CC       Phosphorylation of YAP1 by LATS2 inhibits its translocation into
CC       the nucleus to regulate cellular genes important for cell
CC       proliferation, cell death, and cell migration. MST1/MST2 are
CC       required to repress proliferation of mature hepatocytes, to
CC       prevent activation of facultative adult liver stem cells (oval
CC       cells), and to inhibit tumor formation (By similarity).
CC       Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during
CC       apoptosis. Phosphorylates FOXO3 upon oxidative stress, which
CC       results in its nuclear translocation and cell death initiation.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Inhibited by the C-terminal non-catalytic
CC       region. Activated by caspase-cleavage. Full activation also
CC       requires homodimerization and autophosphorylation of Thr-183.
CC   -!- SUBUNIT: Homodimer; mediated via the coiled-coil region. Interacts
CC       with NORE1, which inhibits autoactivation. Interacts with and
CC       stabilizes SAV1. Interacts with RASSF1, which leads to enzyme
CC       activation. Interacts with FOXO3.
CC   -!- INTERACTION:
CC       Self; NbExp=1; IntAct=EBI-367376, EBI-367376;
CC       Q9NS23:RASSF1; NbExp=1; IntAct=EBI-367376, EBI-367363;
CC       Q8WWW0:RASSF5; NbExp=3; IntAct=EBI-367376, EBI-367390;
CC       Q9H4B6:SAV1; NbExp=2; IntAct=EBI-367376, EBI-1017775;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=The caspase-cleaved
CC       form cycles between the nucleus and cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13043-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13043-2; Sequence=VSP_019851, VSP_019852;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- PTM: Autophosphorylated on serine and threonine residues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SARAH domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/STK4ID42440ch20q11.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U18297; AAA83254.1; -; mRNA.
DR   EMBL; U60207; AAB17262.1; -; mRNA.
DR   EMBL; AK315238; BAG37665.1; -; mRNA.
DR   EMBL; Z93016; CAB07508.2; -; Genomic_DNA.
DR   EMBL; AL109839; CAB07508.2; JOINED; Genomic_DNA.
DR   EMBL; AL109839; CAI95633.1; -; Genomic_DNA.
DR   EMBL; Z93016; CAI95633.1; JOINED; Genomic_DNA.
DR   EMBL; AL109839; CAI95634.1; -; Genomic_DNA.
DR   EMBL; Z93016; CAI95634.1; JOINED; Genomic_DNA.
DR   EMBL; Z93016; CAI19815.1; -; Genomic_DNA.
DR   EMBL; AL109839; CAI19815.1; JOINED; Genomic_DNA.
DR   EMBL; CH471077; EAW75882.1; -; Genomic_DNA.
DR   EMBL; BC029511; AAH29511.1; ALT_SEQ; mRNA.
DR   EMBL; BC058916; AAH58916.1; ALT_SEQ; mRNA.
DR   EMBL; BC093768; AAH93768.1; -; mRNA.
DR   IPI; IPI00011488; -.
DR   IPI; IPI00645585; -.
DR   RefSeq; NP_006273.1; -.
DR   UniGene; Hs.472838; -.
DR   PDB; 2JO8; NMR; -; A/B=432-480.
DR   PDB; 3COM; X-ray; 2.20 A; A/B=2-311.
DR   PDBsum; 2JO8; -.
DR   PDBsum; 3COM; -.
DR   ProteinModelPortal; Q13043; -.
DR   DIP; DIP-32491N; -.
DR   IntAct; Q13043; 16.
DR   MINT; MINT-4658525; -.
DR   STRING; Q13043; -.
DR   PhosphoSite; Q13043; -.
DR   PRIDE; Q13043; -.
DR   Ensembl; ENST00000372806; ENSP00000361892; ENSG00000101109.
DR   GeneID; 6789; -.
DR   KEGG; hsa:6789; -.
DR   UCSC; uc002xnb.1; human.
DR   UCSC; uc010ggx.1; human.
DR   CTD; 6789; -.
DR   GeneCards; GC20P043595; -.
DR   HGNC; HGNC:11408; STK4.
DR   HPA; CAB004038; -.
DR   HPA; CAB004965; -.
DR   HPA; HPA015270; -.
DR   MIM; 604965; gene.
DR   PharmGKB; PA36215; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; Q13043; -.
DR   OMA; KRRDETM; -.
DR   OrthoDB; EOG92JR9N; -.
DR   PhylomeDB; Q13043; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 26508; -.
DR   PMAP-CutDB; Q13043; -.
DR   ArrayExpress; Q13043; -.
DR   Bgee; Q13043; -.
DR   CleanEx; HS_MST1; -.
DR   CleanEx; HS_STK4; -.
DR   Genevestigator; Q13043; -.
DR   GermOnline; ENSG00000101109; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:MGI.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator a...; IDA:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0000902; P:cell morphogenesis; IDA:MGI.
DR   GO; GO:0035329; P:hippo signaling cascade; IDA:BHF-UCL.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt recept...; IMP:BHF-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptosis; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IDA:MGI.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR011524; SARAH.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
DR   PROSITE; PS50951; SARAH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis;
KW   ATP-binding; Coiled coil; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    487       Serine/threonine-protein kinase 4.
FT                                /FTId=PRO_0000086691.
FT   DOMAIN       30    281       Protein kinase.
FT   DOMAIN      433    480       SARAH.
FT   NP_BIND      36     44       ATP (By similarity).
FT   COILED      290    310       Potential.
FT   COMPBIAS    373    378       Poly-Glu.
FT   ACT_SITE    149    149       Proton acceptor (By similarity).
FT   BINDING      59     59       ATP.
FT   SITE        326    327       Cleavage; by caspase-3.
FT   SITE        349    350       Cleavage; by caspase-3.
FT   MOD_RES       1      1       N-acetylmethionine.
FT   MOD_RES       3      3       Phosphothreonine.
FT   MOD_RES      40     40       Phosphoserine.
FT   MOD_RES      41     41       Phosphotyrosine.
FT   MOD_RES     175    175       Phosphothreonine.
FT   MOD_RES     177    177       Phosphothreonine.
FT   MOD_RES     183    183       Phosphothreonine; by autocatalysis.
FT   MOD_RES     265    265       Phosphoserine.
FT   MOD_RES     320    320       Phosphoserine.
FT   MOD_RES     327    327       Phosphoserine.
FT   MOD_RES     329    329       Phosphothreonine.
FT   MOD_RES     340    340       Phosphothreonine.
FT   MOD_RES     353    353       Phosphothreonine.
FT   MOD_RES     360    360       Phosphothreonine.
FT   MOD_RES     367    367       Phosphothreonine.
FT   MOD_RES     380    380       Phosphothreonine.
FT   MOD_RES     387    387       Phosphothreonine.
FT   MOD_RES     394    394       Phosphoserine.
FT   MOD_RES     410    410       Phosphoserine.
FT   MOD_RES     414    414       Phosphoserine.
FT   MOD_RES     422    422       Phosphoserine.
FT   MOD_RES     433    433       Phosphotyrosine.
FT   MOD_RES     438    438       Phosphoserine.
FT   VAR_SEQ     436    462       LKSWTVEDLQKRLLALDPMMEQEIEEI -> KTSQEQQSGK
FT                                DICIQNCQGNLLCRYAF (in isoform 2).
FT                                /FTId=VSP_019851.
FT   VAR_SEQ     463    487       Missing (in isoform 2).
FT                                /FTId=VSP_019852.
FT   VARIANT     162    162       H -> N (in dbSNP:rs55850759).
FT                                /FTId=VAR_041123.
FT   VARIANT     310    310       R -> Q (in dbSNP:rs35447878).
FT                                /FTId=VAR_041124.
FT   VARIANT     312    312       V -> M (in dbSNP:rs17420378).
FT                                /FTId=VAR_027040.
FT   VARIANT     355    355       I -> T (in dbSNP:rs35944046).
FT                                /FTId=VAR_041125.
FT   VARIANT     416    416       P -> L (in dbSNP:rs33963346).
FT                                /FTId=VAR_041126.
FT   MUTAGEN      59     59       K->R: Loss of activity.
FT   MUTAGEN     175    175       T->A: No effect on activity.
FT   MUTAGEN     177    177       T->A: No effect on activity.
FT   MUTAGEN     183    183       T->A: Loss of activity.
FT   MUTAGEN     326    326       D->N: Resistant to proteolytic cleavage
FT                                by caspase during apoptosis; when
FT                                associated with N-349.
FT   MUTAGEN     349    349       D->N: Resistant to proteolytic cleavage
FT                                by caspase during apoptosis; when
FT                                associated with N-326.
FT   MUTAGEN     444    444       L->P: Loss of homodimerization,
FT                                activation, and autophosphorylation.
FT   CONFLICT    222    222       P -> R (in Ref. 1; AAA83254).
FT   HELIX        19     22
FT   STRAND       30     35
FT   STRAND       43     49
FT   TURN         50     52
FT   STRAND       55     62
FT   HELIX        68     78
FT   STRAND       88     94
FT   STRAND       97    103
FT   HELIX       110    117
FT   HELIX       123    142
FT   HELIX       152    154
FT   STRAND      155    157
FT   STRAND      163    165
FT   HELIX       188    190
FT   HELIX       193    196
FT   STRAND      197    199
FT   HELIX       205    219
FT   TURN        223    226
FT   HELIX       229    238
FT   HELIX       247    249
FT   HELIX       252    261
FT   TURN        266    268
FT   HELIX       272    275
FT   HELIX       279    282
FT   HELIX       287    290
FT   HELIX       291    297
SQ   SEQUENCE   487 AA;  55630 MW;  150758EBC5F77D5C CRC64;
     METVQLRNPP RRQLKKLDED SLTKQPEEVF DVLEKLGEGS YGSVYKAIHK ETGQIVAIKQ
     VPVESDLQEI IKEISIMQQC DSPHVVKYYG SYFKNTDLWI VMEYCGAGSV SDIIRLRNKT
     LTEDEIATIL QSTLKGLEYL HFMRKIHRDI KAGNILLNTE GHAKLADFGV AGQLTDTMAK
     RNTVIGTPFW MAPEVIQEIG YNCVADIWSL GITAIEMAEG KPPYADIHPM RAIFMIPTNP
     PPTFRKPELW SDNFTDFVKQ CLVKSPEQRA TATQLLQHPF VRSAKGVSIL RDLINEAMDV
     KLKRQESQQR EVDQDDEENS EEDEMDSGTM VRAVGDEMGT VRVASTMTDG ANTMIEHDDT
     LPSQLGTMVI NAEDEEEEGT MKRRDETMQP AKPSFLEYFE QKEKENQINS FGKSVPGPLK
     NSSDWKIPQD GDYEFLKSWT VEDLQKRLLA LDPMMEQEIE EIRQKYQSKR QPILDAIEAK
     KRRQQNF
//
